Google X Staff Meet With FDA Pointing Toward New Device<\/h1>\n\nBy Brian Womack and Anna Edney\u00a0\u00a0Jan 10, 2014 4:01 PM ET<\/p>\nGoogle Inc. (GOOG)<\/a>\u00a0sent employees with ties to its secretive X research group to meet with U.S. regulators who oversee medical devices, raising the possibility of a new product that may involve biosensors from the unit that developed computerized glasses.<\/span><\/a><\/div>\n<\/div>\n\nThe meeting included at least four Google workers, some of whom have connections with Google X — and have done research on sensors, including contact lenses that help wearers monitor their biological data. Google staff met with those at the Food and Drug Administration who regulate eye devices and diagnostics for heart conditions, according to the agency\u2019s public calendar.<\/p>\n
As technology and medicine merge to give consumers more control over their health, innovators from mobile-health application developers to DNA analysis companies have struggled to meet the demands of federal oversight. The FDA ordered Google-backed 23andMe Inc. in November to halt sales of its personal gene test, saying it hadn\u2019t gained agency approval.<\/p>\n
Google, expanding beyond its core search-engine business, is investing in long-term projects at its X lab that may lead to new market opportunities, including the Glass devices, driverless cars and high-altitude air balloons to provide wireless Internet access. While some projects may not deliver significant profits and revenue, the company is committed to making bets on research and development, according to Chief Executive Officer\u00a0Larry Page<\/a>.<\/p>\n![\"\"](\"http:\/\/www.bloomberg.com\/image\/iYDK3th5LQ3g.jpg\")
<\/a>Photographer: David Paul Morris\/Bloomberg<\/figcaption>\nGoogle has introduced Glass devices, computerized eyewear that lets users check e-mail…\u00a0Read More<\/a><\/p>\n<\/div>\n<\/figure>\n\u201cOur main job is to figure out how to obviously invest more to achieve greater outcomes for the world, for the company,\u201d Page said during a call with analysts last July. \u201cAnd I think those opportunities are clearly there.\u201d<\/p>\n
Google Glass<\/h2>\n
Already, Google has introduced Glass devices, computerized eyewear that lets users check e-mail or access their favorite music. The devices, now being used by testers and developers, aren\u2019t yet widely available for consumers.<\/p>\n
FDA\u2019s public calendar also shows the Google representatives met with the head of the agency\u2019s office that reviews device applications for marketing approval, and the FDA adviser who wrote the agency\u2019s guidelines for mobile medical apps. The FDA classified Google\u2019s visit to Silver Spring,\u00a0Maryland<\/a>, where the agency is based, as a meet and greet. Jennifer Rodriguez, a spokeswoman for the agency, confirmed the meeting and declined to provide further information.<\/p>\nOne of the Google participants was Andrew Conrad, who joined X last year. Conrad is a former chief scientist at\u00a0Laboratory Corporation of America Holdings<\/a>\u00a0and co-founder of its National Genetics Institute.<\/p>\n![\"\"](\"http:\/\/www.bloomberg.com\/image\/iphtYPKIDb8o.jpg\")
<\/a>Photographer: Krisztian Bocsi\/Bloomberg<\/figcaption>\nA Google Inc. logo sits on a wall outside the entrance to the company’s offices in Berlin.<\/p>\n<\/div>\n<\/figure>\n
Among other attendees was\u00a0Brian Otis<\/a>\u00a0and Zenghe \u201cZach\u201d Liu. Courtney Hohne, a spokeswoman for Mountain View, California-based Google, didn\u2019t return messages seeking comment on the company\u2019s meeting with the FDA.<\/p>\nEngineering Work<\/h2>\n
Otis is on leave to Google from the University ofWashington<\/a>\u00a0in\u00a0Seattle<\/a>, where he is an associate professor in the electrical engineering department, according to the university\u2019s website. Otis has worked on biosensors and holds a patent that involves a wireless powered contact lens with a biosensor.<\/p>\nOne of Otis\u2019 colleagues is Babak Parviz, who was involved in the Google Glass project and has talked about putting displays on contact lenses, including lenses that monitor wearer\u2019s health.<\/p>\n
\u201cNoninvasive monitoring of the wearer\u2019s biomarkers and health indicators could be a huge future market,\u201d Parviz wrote in a 2009 paper titled \u201cAugmented Reality in a Contact Lens.\u201d<\/p>\n
In 2012, the two were among the co-authors in a\u00a0paper<\/a>\u00a0titled \u201cGlucose Sensor for Wireless Contact-Lens Tear Glucose Monitoring\u201d for the IEEE Journal of Solid-State Circuits.<\/p>\n\u2018Wearable\u2019 Lenses<\/h2>\n
\u201cAdvances in technology scaling, sensor devices, and ultra low-power circuit design techniques have now made it possible to integrate complex wireless electronics onto the surface of a wearable contact lens,\u201d according to the paper.<\/p>\n
In a presentation, Parviz said a tear drop provides many different components to give sensors various types of information about how a body is operating.<\/p>\n
\u201cThere is actually one interface on the surface of the body that can literally provide us with a window of what happens inside, and that\u2019s the surface of the eye,\u201d Parviz said in a\u00a0video<\/a>\u00a0posted on YouTube. \u201cIt\u2019s a very interesting chemical interface.\u201d<\/p>\nLiu, formerly with the medical-device manufacturer\u00a0Abbott Laboratories (ABT)<\/a>, also holds a patent that involves devices that use bodily fluids to read levels of human substances such as glucose or cholesterol.<\/p>\nTo contact the reporters on this story: Brian Womack in San Francisco atbwomack1@bloomberg.net<\/a>; Anna Edney in Washington at\u00a0aedney@bloomberg.net<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"Interesting highly-speculative piece on Google’s visit to the FDA for a meet and greet. The eye is a great place to stick a sensor given it’s continuity with the innards. It’s also a great place to view the innards. While we’re there, why not be powered by the innards at the same time? http:\/\/www.bloomberg.com\/news\/2014-01-10\/google-x-staff-meet-with-fda-pointing-toward-new-device.html Google … Continue reading Google mucking around with contact lenses and health data<\/span>
The meeting included at least four Google workers, some of whom have connections with Google X — and have done research on sensors, including contact lenses that help wearers monitor their biological data. Google staff met with those at the Food and Drug Administration who regulate eye devices and diagnostics for heart conditions, according to the agency\u2019s public calendar.<\/p>\n
As technology and medicine merge to give consumers more control over their health, innovators from mobile-health application developers to DNA analysis companies have struggled to meet the demands of federal oversight. The FDA ordered Google-backed 23andMe Inc. in November to halt sales of its personal gene test, saying it hadn\u2019t gained agency approval.<\/p>\n
Google, expanding beyond its core search-engine business, is investing in long-term projects at its X lab that may lead to new market opportunities, including the Glass devices, driverless cars and high-altitude air balloons to provide wireless Internet access. While some projects may not deliver significant profits and revenue, the company is committed to making bets on research and development, according to Chief Executive Officer\u00a0Larry Page<\/a>.<\/p>\n Google has introduced Glass devices, computerized eyewear that lets users check e-mail…\u00a0Read More<\/a><\/p>\n<\/div>\n<\/figure>\n \u201cOur main job is to figure out how to obviously invest more to achieve greater outcomes for the world, for the company,\u201d Page said during a call with analysts last July. \u201cAnd I think those opportunities are clearly there.\u201d<\/p>\n Already, Google has introduced Glass devices, computerized eyewear that lets users check e-mail or access their favorite music. The devices, now being used by testers and developers, aren\u2019t yet widely available for consumers.<\/p>\n FDA\u2019s public calendar also shows the Google representatives met with the head of the agency\u2019s office that reviews device applications for marketing approval, and the FDA adviser who wrote the agency\u2019s guidelines for mobile medical apps. The FDA classified Google\u2019s visit to Silver Spring,\u00a0Maryland<\/a>, where the agency is based, as a meet and greet. Jennifer Rodriguez, a spokeswoman for the agency, confirmed the meeting and declined to provide further information.<\/p>\n One of the Google participants was Andrew Conrad, who joined X last year. Conrad is a former chief scientist at\u00a0Laboratory Corporation of America Holdings<\/a>\u00a0and co-founder of its National Genetics Institute.<\/p>\n A Google Inc. logo sits on a wall outside the entrance to the company’s offices in Berlin.<\/p>\n<\/div>\n<\/figure>\n Among other attendees was\u00a0Brian Otis<\/a>\u00a0and Zenghe \u201cZach\u201d Liu. Courtney Hohne, a spokeswoman for Mountain View, California-based Google, didn\u2019t return messages seeking comment on the company\u2019s meeting with the FDA.<\/p>\n Otis is on leave to Google from the University ofWashington<\/a>\u00a0in\u00a0Seattle<\/a>, where he is an associate professor in the electrical engineering department, according to the university\u2019s website. Otis has worked on biosensors and holds a patent that involves a wireless powered contact lens with a biosensor.<\/p>\n One of Otis\u2019 colleagues is Babak Parviz, who was involved in the Google Glass project and has talked about putting displays on contact lenses, including lenses that monitor wearer\u2019s health.<\/p>\n \u201cNoninvasive monitoring of the wearer\u2019s biomarkers and health indicators could be a huge future market,\u201d Parviz wrote in a 2009 paper titled \u201cAugmented Reality in a Contact Lens.\u201d<\/p>\n In 2012, the two were among the co-authors in a\u00a0paper<\/a>\u00a0titled \u201cGlucose Sensor for Wireless Contact-Lens Tear Glucose Monitoring\u201d for the IEEE Journal of Solid-State Circuits.<\/p>\n \u201cAdvances in technology scaling, sensor devices, and ultra low-power circuit design techniques have now made it possible to integrate complex wireless electronics onto the surface of a wearable contact lens,\u201d according to the paper.<\/p>\n In a presentation, Parviz said a tear drop provides many different components to give sensors various types of information about how a body is operating.<\/p>\n \u201cThere is actually one interface on the surface of the body that can literally provide us with a window of what happens inside, and that\u2019s the surface of the eye,\u201d Parviz said in a\u00a0video<\/a>\u00a0posted on YouTube. \u201cIt\u2019s a very interesting chemical interface.\u201d<\/p>\n Liu, formerly with the medical-device manufacturer\u00a0Abbott Laboratories (ABT)<\/a>, also holds a patent that involves devices that use bodily fluids to read levels of human substances such as glucose or cholesterol.<\/p>\n To contact the reporters on this story: Brian Womack in San Francisco atbwomack1@bloomberg.net<\/a>; Anna Edney in Washington at\u00a0aedney@bloomberg.net<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":" Interesting highly-speculative piece on Google’s visit to the FDA for a meet and greet. The eye is a great place to stick a sensor given it’s continuity with the innards. It’s also a great place to view the innards. While we’re there, why not be powered by the innards at the same time? http:\/\/www.bloomberg.com\/news\/2014-01-10\/google-x-staff-meet-with-fda-pointing-toward-new-device.html Google … Continue reading Google mucking around with contact lenses and health data<\/span> <\/a>Google Glass<\/h2>\n
<\/a>Engineering Work<\/h2>\n
\u2018Wearable\u2019 Lenses<\/h2>\n